Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Share-based Compensation (2025 - 2026)

Updated

Adaptin Bio (APTN) posted Share-based Compensation of $193,806 for Q2 2026, down 43.9% from the prior quarter.

Analysis

Adaptin Bio (APTN) Share-based Compensation (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Adaptin Bio was $784,327; for FY2025, it came in at $1.02 million.

  • Quarterly Share-based Compensation has run from a low of -$75,000 in Q4 2025 to a high of $345,396 in Q1 2026 over five years.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $345,396 (Q1 2026), -$75,000 (Q4 2025) and $320,125 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 357.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 160.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 234.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 362.00 Mn
10 Adaptin Bio 56.76 Mn 54.75 Mn - 193,806.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 193,806.00
Mar 31, 2026 345,396.00
Dec 31, 2025 -75,000.00
Sep 30, 2025 320,125.00
API Access

Adaptin Bio Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=APTN&period=max&api_key=YOUR_API_KEY